https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:24656 Wed 17 Nov 2021 16:28:55 AEDT ]]> Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES) https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:13823 Tue 24 Aug 2021 14:27:18 AEST ]]> 96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:55154 Tue 16 Apr 2024 15:25:19 AEST ]]> Latent psychotic symptom profiles amongst people who use methamphetamine: what do they tell us about existing diagnostic categories? https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:35402 Thu 27 Jan 2022 15:58:30 AEDT ]]> Ensuring the safety of new medications and devices: are naltrexone implants safe? (editorial) https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:5653 Sat 24 Mar 2018 07:44:05 AEDT ]]> Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46800 Mon 05 Dec 2022 08:29:28 AEDT ]]> The contribution of methamphetamine use to crime: evidence from Australian longitudinal data https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:40590 Fri 22 Jul 2022 15:33:22 AEST ]]>